| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.699 | 0.002 | 0.699 | Aromatase inhibitor | 0.19 0.009 DBMET02982 0.134 0.015 DBMET00376 | ||
| 0.418 | 0.004 | 0.418 | Cannabinoid receptor antagonist | 0.184 0.01 DBMET02982 0.095 0.031 DBMET00376 | ||
| 0.394 | 0.003 | 0.394 | Cannabinoid CB1 receptor antagonist | 0.162 0.006 DBMET02982 0.083 0.025 DBMET00376 | ||
| 0.301 | 0.003 | 0.301 | Lanosterol 14 alpha demethylase inhibitor | 0.118 0.033 DBMET02982 0.122 0.029 DBMET00376 | ||
| 0.282 | 0.015 | 0.282 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.258 | 0.014 | 0.274 | Cell wall synthesis inhibitor | 0.147 0.068 DBMET02982 0.158 0.058 DBMET00376 0.274 0.012 DBMET02983 | DBMET02983 | |
| 0.228 | 0.01 | 0.494 | DNA directed RNA polymerase inhibitor | 0.494 0.004 DBMET02982 0.314 0.006 DBMET00376 0.121 0.036 DBMET02983 | DBMET02982 | |
| 0.205 | 0.016 | 0.205 | GABA receptor agonist | 0.129 0.049 DBMET02982 | ||
| 0.183 | 0.002 | 0.183 | Estrone sulfatase inhibitor | 0.033 0.01 DBMET02982 | ||
| 0.298 | 0.117 | 0.447 | GABA C receptor rho-3 antagonist | 0.447 0.043 DBMET02982 0.325 0.1 DBMET00376 | DBMET02982 | |
| 0.169 | 0.018 | 0.633 | Uric acid excretion stimulant | 0.633 0.003 DBMET02982 0.452 0.004 DBMET00376 0.338 0.005 DBMET02983 | DBMET02982 | |
| 0.133 | 0.019 | 0.133 | GABA A receptor agonist | 0.088 0.051 DBMET02982 | ||
| 0.115 | 0.004 | 0.115 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.112 | 0.005 | 0.125 | Exportin-1 inhibitor | 0.125 0.004 DBMET02982 0.076 0.032 DBMET00376 | DBMET02982 | |
| 0.147 | 0.043 | 0.147 | Protein kinase (CK2) alpha inhibitor | 0.124 0.06 DBMET02982 0.096 0.08 DBMET00376 | ||
| 0.187 | 0.084 | 0.218 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.218 0.059 DBMET02982 0.217 0.059 DBMET00376 0.173 0.103 DBMET02983 | DBMET02982 | |
| 0.105 | 0.003 | 0.105 | Heme oxygenase inhibitor | 0.049 0.014 DBMET02982 0.047 0.018 DBMET00376 | ||
| 0.146 | 0.052 | 0.167 | Ca2+-transporting ATPase inhibitor | 0.162 0.021 DBMET02982 0.167 0.015 DBMET00376 0.167 0.015 DBMET02983 | DBMET02983 | |
| 0.183 | 0.096 | 0.274 | Anticonvulsant | 0.188 0.092 DBMET02982 0.274 0.048 DBMET00376 | DBMET00376 | |
| 0.115 | 0.029 | 0.2 | CYP2A6 inhibitor | 0.2 0.008 DBMET02982 0.156 0.015 DBMET00376 | DBMET02982 | |
| 0.08 | 0.012 | 0.341 | Farnesyltransferase inhibitor | 0.249 0.004 DBMET02982 0.341 0.003 DBMET00376 0.05 0.027 DBMET02983 | DBMET00376 | |
| 0.079 | 0.014 | 0.079 | Dipeptidyl peptidase inhibitor | 0.057 0.029 DBMET02982 | ||
| 0.074 | 0.009 | 0.074 | Glutamate (mGluR4) antagonist | 0.046 0.026 DBMET02982 0.04 0.037 DBMET00376 | ||
| 0.118 | 0.055 | 0.207 | GABA C receptor antagonist | 0.204 0.012 DBMET02982 0.207 0.011 DBMET00376 | DBMET00376 | |
| 0.108 | 0.046 | 0.126 | Glutamate (mGluR7) agonist | 0.108 0.046 DBMET02982 0.126 0.025 DBMET00376 | DBMET00376 | |
| 0.087 | 0.031 | 0.087 | Toll-Like receptor 7 antagonist | 0.08 0.038 DBMET02982 | ||
| 0.111 | 0.056 | 0.256 | GABA C receptor agonist | 0.253 0.013 DBMET02982 0.256 0.013 DBMET00376 | DBMET00376 | |
| 0.065 | 0.011 | 0.065 | Dipeptidyl peptidase IV inhibitor | 0.047 0.024 DBMET02982 | ||
| 0.057 | 0.009 | 0.066 | Glutamate (mGluR3) antagonist | 0.04 0.02 DBMET02982 0.066 0.007 DBMET00376 | DBMET00376 | |
| 0.051 | 0.004 | 0.051 | Egl nine homolog 2 inhibitor | 0.02 0.005 DBMET02982 0.014 0.007 DBMET00376 | ||
| 0.065 | 0.018 | 0.065 | Oleamide hydrolase inhibitor | 0.062 0.019 DBMET02982 | ||
| 0.071 | 0.026 | 0.071 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.058 0.049 DBMET02982 | ||
| 0.08 | 0.035 | 0.095 | Potassium channel (Tandem pore domain) blocker | 0.095 0.012 DBMET02982 0.09 0.017 DBMET00376 | DBMET02982 | |
| 0.141 | 0.097 | 0.141 | Heat shock protein 90 alpha antagonist | |||
| 0.126 | 0.083 | 0.127 | Sphingosine 1-phosphate receptor 2 antagonist | 0.127 0.08 DBMET02982 0.116 0.109 DBMET00376 | DBMET02982 | |
| 0.063 | 0.024 | 0.076 | Thromboxane synthase inhibitor | 0.051 0.047 DBMET02982 0.076 0.014 DBMET00376 | DBMET00376 | |
| 0.091 | 0.055 | 0.462 | NADH dehydrogenase inhibitor | 0.154 0.017 DBMET02982 0.184 0.012 DBMET00376 0.462 0.004 DBMET02983 | DBMET02983 | |
| 0.205 | 0.169 | 0.223 | Thioredoxin glutathione reductase inhibitor | 0.223 0.153 DBMET02982 | DBMET02982 | |
| 0.131 | 0.097 | 0.141 | Sphingosine 1-phosphate receptor 5 antagonist | 0.141 0.077 DBMET02982 0.13 0.101 DBMET00376 | DBMET02982 | |
| 0.081 | 0.048 | 0.166 | Glutamate (mGluR) antagonist | 0.166 0.014 DBMET02982 | DBMET02982 | |
| 0.098 | 0.065 | 0.098 | Protein kinase (CK2) inhibitor | 0.095 0.068 DBMET02982 | ||
| 0.061 | 0.028 | 0.061 | Sphingosine 1-phosphate receptor 1 antagonist | 0.06 0.03 DBMET00376 | ||
| 0.033 | 0.003 | 0.033 | Egl nine homolog 3 inhibitor | |||
| 0.066 | 0.037 | 0.078 | Calcium channel P-type blocker | 0.078 0.016 DBMET02982 0.077 0.017 DBMET00376 | DBMET02982 | |
| 0.04 | 0.014 | 0.04 | 5 Hydroxytryptamine 1D agonist | |||
| 0.05 | 0.026 | 0.05 | Benzodiazepine inverse agonist | |||
| 0.043 | 0.021 | 0.058 | Glutamate (mGluR group II) antagonist | 0.058 0.012 DBMET00376 | DBMET00376 | |
| 0.048 | 0.027 | 0.048 | CDK7/cyclin H inhibitor | |||
| 0.039 | 0.018 | 0.039 | Glucose-dependent insulinotropic receptor agonist | 0.035 0.024 DBMET02982 | ||
| 0.073 | 0.052 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.075 0.048 DBMET02982 0.069 0.063 DBMET00376 | DBMET02982 | |
| 0.033 | 0.013 | 0.041 | MAP3K8 inhibitor | 0.041 0.006 DBMET02982 0.032 0.015 DBMET00376 | DBMET02982 | |
| 0.029 | 0.009 | 0.291 | Geranylgeranyltransferase I inhibitor | 0.111 0.004 DBMET02982 0.291 0.002 DBMET00376 0.025 0.011 DBMET02983 | DBMET00376 | |
| 0.109 | 0.09 | 0.632 | Alpha-N-acetylglucosaminidase inhibitor | 0.336 0.013 DBMET02982 0.443 0.007 DBMET00376 0.632 0.004 DBMET02983 | DBMET02983 | |
| 0.124 | 0.107 | 0.125 | Heat shock protein 90 antagonist | 0.125 0.104 DBMET02982 | DBMET02982 | |
| 0.101 | 0.085 | 0.179 | Acetylcholine release stimulant | 0.179 0.006 DBMET02982 0.106 0.075 DBMET00376 0.125 0.04 DBMET02983 | DBMET02982 | |
| 0.213 | 0.198 | 0.443 | 15-Lipoxygenase inhibitor | 0.443 0.057 DBMET02982 | DBMET02982 | |
| 0.032 | 0.018 | 0.041 | Glutamate (mGluR2) antagonist | 0.041 0.011 DBMET00376 | DBMET00376 | |
| 0.019 | 0.006 | 0.019 | Egl nine homolog 1 inhibitor | |||
| 0.044 | 0.031 | 0.044 | Glutamate (mGluR group III) antagonist | |||
| 0.049 | 0.037 | 0.049 | Alpha 1b adrenoreceptor agonist | |||
| 0.078 | 0.071 | 0.115 | CC chemokine 5 receptor agonist | 0.115 0.01 DBMET02982 0.098 0.024 DBMET00376 | DBMET02982 | |
| 0.138 | 0.133 | 0.2 | Phospholipase C inhibitor | 0.186 0.054 DBMET02982 0.2 0.044 DBMET00376 0.183 0.058 DBMET02983 | DBMET00376 | |
| 0.125 | 0.121 | 0.412 | Interferon gamma antagonist | 0.304 0.019 DBMET02982 0.239 0.03 DBMET00376 0.412 0.01 DBMET02983 | DBMET02983 | |
| 0.192 | 0.189 | 0.528 | Vasodilator, coronary | 0.4 0.035 DBMET02982 0.379 0.043 DBMET00376 0.528 0.012 DBMET02983 | DBMET02983 | |
| 0.042 | 0.039 | 0.042 | Adenosine deaminase inhibitor | |||
| 0.034 | 0.031 | 0.035 | G protein-coupled receptor agonist | 0.035 0.03 DBMET02982 | DBMET02982 | |
| 0.035 | 0.033 | 0.035 | Alpha 1d adrenoreceptor agonist | |||
| 0.043 | 0.041 | 0.043 | CC chemokine 4 receptor antagonist | |||
| 0.017 | 0.016 | 0.034 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.034 0.008 DBMET00376 | DBMET00376 | |
| 0.042 | 0.043 | 0.126 | Cannabinoid CB2 receptor antagonist | 0.126 0.01 DBMET02982 | DBMET02982 | |
| 0.063 | 0.064 | 0.104 | MDM2 inhibitor | 0.104 0.006 DBMET02982 0.073 0.031 DBMET00376 | DBMET02982 | |
| 0.035 | 0.036 | 0.041 | AMPA 4 receptor antagonist | 0.041 0.025 DBMET02982 0.04 0.026 DBMET00376 | DBMET02982 | |
| 0.042 | 0.044 | 0.162 | Aldosterone antagonist | 0.162 0.005 DBMET02982 0.072 0.013 DBMET00376 | DBMET02982 | |
| 0.083 | 0.085 | 0.269 | Xanthine oxidase inhibitor | 0.269 0.01 DBMET02982 0.156 0.032 DBMET00376 0.266 0.01 DBMET02983 | DBMET02982 | |
| 0.025 | 0.029 | 0.054 | Nicotinic alpha3beta4 receptor agonist | 0.054 0.005 DBMET02982 0.032 0.017 DBMET00376 | DBMET02982 | |
| 0.112 | 0.116 | 0.265 | Mannose-6-phosphate isomerase inhibitor | 0.265 0.009 DBMET02982 0.18 0.042 DBMET00376 0.218 0.022 DBMET02983 | DBMET02982 | |
| 0.004 | 0.009 | 0.01 | CC chemokine 6 receptor agonist | 0.01 0.003 DBMET02982 0.006 0.004 DBMET00376 | DBMET02982 | |
| 0.035 | 0.041 | 0.037 | Thymidine kinase inhibitor | 0.037 0.036 DBMET00376 | DBMET00376 | |
| 0.06 | 0.067 | 0.099 | Benzodiazepine agonist | 0.099 0.026 DBMET02982 | DBMET02982 | |
| 0.017 | 0.024 | 0.072 | Geranylgeranyltransferase inhibitor | 0.038 0.006 DBMET02982 0.072 0.004 DBMET00376 | DBMET00376 | |
| 0.037 | 0.044 | 0.048 | Geranyltranstransferase inhibitor | 0.048 0.025 DBMET02982 | DBMET02982 | |
| 0.104 | 0.111 | 0.126 | Sphingosine 1-phosphate receptor 4 antagonist | 0.126 0.061 DBMET02982 | DBMET02982 | |
| 0.055 | 0.063 | 0.091 | Heme oxygenase stimulant | 0.091 0.009 DBMET02982 0.082 0.014 DBMET00376 0.058 0.054 DBMET02983 | DBMET02982 | |
| 0.102 | 0.11 | 0.216 | Toll-Like receptor 9 antagonist | 0.216 0.029 DBMET02982 | DBMET02982 | |
| 0.053 | 0.063 | 0.059 | Fibroblast growth factor 2 antagonist | 0.059 0.053 DBMET02982 | DBMET02982 | |
| 0.031 | 0.042 | 0.046 | Vascular adhesion protein 1 inhibitor | 0.046 0.019 DBMET02982 | DBMET02982 | |
| 0.038 | 0.049 | 0.051 | AMPA receptor antagonist | 0.051 0.03 DBMET02982 | DBMET02982 | |
| 0.072 | 0.084 | 0.079 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.079 0.073 DBMET02982 | DBMET02982 | |
| 0.193 | 0.206 | 0.319 | Ca(v)3.3 blocker | 0.319 0.028 DBMET02982 | DBMET02982 | |
| 0.026 | 0.04 | 0.042 | Dipeptidyl peptidase II inhibitor | 0.042 0.013 DBMET02982 | DBMET02982 | |
| 0.259 | 0.273 | 0.405 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.405 0.096 DBMET02982 0.352 0.148 DBMET00376 | DBMET02982 | |
| 0.095 | 0.111 | 0.143 | Estrogen antagonist | 0.143 0.026 DBMET02982 0.117 0.06 DBMET00376 | DBMET02982 | |
| 0.053 | 0.07 | 0.1 | Nav1.7 sodium channel blocker | 0.1 0.023 DBMET02982 | DBMET02982 | |
| 0.04 | 0.058 | 0.054 | Toll-Like receptor 8 antagonist | 0.054 0.037 DBMET02982 | DBMET02982 | |
| 0.028 | 0.047 | 0.194 | Urate transporter 1 inhibitor | 0.194 0.003 DBMET02982 0.184 0.004 DBMET00376 | DBMET02982 | |
| 0.168 | 0.187 | 0.231 | Neuropeptide Y2 antagonist | 0.231 0.075 DBMET02982 0.199 0.121 DBMET00376 | DBMET02982 | |
| 0.064 | 0.083 | 0.121 | Vanilloid 4 agonist | 0.121 0.006 DBMET02982 0.115 0.008 DBMET00376 | DBMET02982 | |
| 0.045 | 0.066 | 0.157 | Dihydroorotate oxidase inhibitor | 0.157 0.003 DBMET02982 0.112 0.004 DBMET00376 | DBMET02982 | |
| 0.026 | 0.048 | 0.037 | AMPA receptor agonist | 0.037 0.022 DBMET02982 | DBMET02982 | |
| 0.074 | 0.097 | 0.136 | Creatine kinase inhibitor | 0.134 0.032 DBMET02982 0.136 0.031 DBMET00376 | DBMET00376 | |
| 0.072 | 0.096 | 0.196 | Breast cancer-resistant protein inhibitor | 0.196 0.014 DBMET02982 | DBMET02982 | |
| 0.095 | 0.119 | 0.169 | Sodium channel (voltage-gated) blocker | 0.169 0.042 DBMET02982 0.124 0.08 DBMET00376 | DBMET02982 | |
| 0.1 | 0.125 | 0.169 | Nav1.6 sodium channel blocker | 0.116 0.102 DBMET02982 0.169 0.036 DBMET00376 | DBMET00376 | |
| 0.022 | 0.048 | 0.037 | Hedgehog signaling activator | 0.035 0.007 DBMET02982 0.037 0.005 DBMET00376 | DBMET00376 | |
| 0.177 | 0.204 | 0.49 | Vasodilator, peripheral | 0.375 0.064 DBMET02982 0.436 0.044 DBMET00376 0.49 0.03 DBMET02983 | DBMET02983 | |
| 0.084 | 0.111 | 0.193 | Multidrug resistance-associated protein 1 inhibitor | 0.193 0.012 DBMET02982 0.148 0.026 DBMET02983 | DBMET02982 | |
| 0.076 | 0.105 | 0.25 | Ferrochelatase inhibitor | 0.22 0.018 DBMET02982 0.25 0.013 DBMET00376 | DBMET00376 | |
| 0.029 | 0.058 | 0.174 | Potassium channel Kv1.1 blocker | 0.174 0.003 DBMET02982 0.05 0.013 DBMET00376 | DBMET02982 | |
| 0.118 | 0.149 | 0.191 | CF transmembrane conductance regulator agonist | 0.191 0.027 DBMET02982 0.178 0.038 DBMET00376 0.178 0.038 DBMET02983 | DBMET02982 | |
| 0.056 | 0.086 | 0.132 | Glutamate dehydrogenase inhibitor | 0.113 0.025 DBMET02982 0.132 0.019 DBMET00376 0.089 0.037 DBMET02983 | DBMET00376 | |
| 0.034 | 0.065 | 0.071 | Mineralocorticoid receptor antagonist | 0.067 0.016 DBMET02982 0.071 0.014 DBMET00376 | DBMET00376 | |
| 0.009 | 0.04 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.013 DBMET02982 | DBMET02982 | |
| 0.097 | 0.131 | 0.376 | Peroxidase inhibitor | 0.359 0.027 DBMET02982 0.376 0.024 DBMET00376 | DBMET00376 | |
| 0.04 | 0.074 | 0.106 | Carbamoyl phosphate synthetase inhibitor | 0.087 0.025 DBMET02982 0.106 0.019 DBMET00376 0.053 0.051 DBMET02983 | DBMET00376 | |
| 0.055 | 0.09 | 0.07 | Histamine H1 receptor antagonist | 0.07 0.069 DBMET00376 | DBMET00376 | |
| 0.071 | 0.106 | 0.126 | Estrogen-related receptor beta agonist | 0.126 0.008 DBMET02982 0.121 0.01 DBMET00376 | DBMET02982 | |
| 0.03 | 0.066 | 0.099 | Vanilloid 3 antagonist | 0.066 0.004 DBMET02982 0.099 0.003 DBMET00376 | DBMET00376 | |
| 0.033 | 0.07 | 0.117 | Xanthine dehydrogenase inhibitor | 0.117 0.012 DBMET02982 0.09 0.019 DBMET00376 0.068 0.033 DBMET02983 | DBMET02982 | |
| 0.09 | 0.129 | 0.151 | Cathepsin H inhibitor | 0.151 0.046 DBMET02982 0.135 0.059 DBMET00376 | DBMET02982 | |
| 0.068 | 0.107 | 0.171 | MAP kinase kinase kinase inhibitor | 0.171 0.027 DBMET02982 | DBMET02982 | |
| 0.082 | 0.123 | 0.245 | DOPA decarboxylase inhibitor | 0.245 0.004 DBMET02982 0.16 0.017 DBMET00376 | DBMET02982 | |
| 0.036 | 0.078 | 0.045 | Dopamine beta hydroxylase inhibitor | 0.045 0.044 DBMET02982 | DBMET02982 | |
| 0.078 | 0.122 | 0.215 | Adenylate kinase inhibitor | 0.215 0.013 DBMET02982 0.153 0.025 DBMET00376 0.117 0.046 DBMET02983 | DBMET02982 | |
| 0.018 | 0.064 | 0.103 | Cholesterol ester transfer protein antagonist | 0.064 0.004 DBMET02982 0.103 0.003 DBMET00376 | DBMET00376 | |
| 0.031 | 0.078 | 0.051 | Cathepsin F inhibitor | 0.051 0.011 DBMET02982 0.044 0.023 DBMET00376 | DBMET02982 | |
| 0.036 | 0.083 | 0.122 | Lysine-specific demethylase 1A inhibitor | 0.122 0.005 DBMET02982 0.081 0.012 DBMET00376 | DBMET02982 | |
| 0.033 | 0.083 | 0.119 | Cannabinoid CB1 receptor agonist | 0.119 0.015 DBMET02982 | DBMET02982 | |
| 0.031 | 0.082 | 0.092 | Acyl-CoA dehydrogenase inhibitor | 0.076 0.024 DBMET02982 0.092 0.018 DBMET00376 | DBMET00376 | |
| 0.157 | 0.208 | 0.395 | Hypoxia-inducible factor 1 alpha inhibitor | 0.395 0.031 DBMET02982 0.269 0.084 DBMET00376 0.261 0.09 DBMET02983 | DBMET02982 | |
| 0.035 | 0.088 | 0.128 | Biliverdin reductase inhibitor | 0.1 0.019 DBMET02982 0.128 0.012 DBMET00376 0.076 0.028 DBMET02983 | DBMET00376 | |
| 0.036 | 0.09 | 0.093 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.068 0.027 DBMET02982 0.086 0.018 DBMET00376 0.093 0.016 DBMET02983 | DBMET02983 | |
| 0.033 | 0.088 | 0.165 | Potassium channel (ATP-sensitive) activator | 0.12 0.003 DBMET02982 0.165 0.003 DBMET00376 0.048 0.033 DBMET02983 | DBMET00376 | |
| 0.035 | 0.09 | 0.167 | Potassium channel (Inward rectifier) activator | 0.122 0.004 DBMET02982 0.167 0.003 DBMET00376 0.051 0.034 DBMET02983 | DBMET00376 | |
| 0.031 | 0.088 | 0.178 | Alcohol oxidase inhibitor | 0.144 0.011 DBMET02982 0.178 0.008 DBMET00376 | DBMET00376 | |
| 0.073 | 0.13 | 0.385 | AMP-activated protein kinase stimulant | 0.158 0.024 DBMET02982 0.145 0.032 DBMET00376 0.385 0.004 DBMET02983 | DBMET02983 | |
| 0.026 | 0.083 | 0.047 | Sphingosine 1-phosphate receptor agonist | 0.047 0.028 DBMET02982 | DBMET02982 | |
| 0.028 | 0.086 | 0.049 | AICAR transformylase inhibitor | 0.045 0.029 DBMET02982 0.049 0.023 DBMET00376 | DBMET00376 | |
| 0.065 | 0.124 | 0.438 | UDP-glucose 4-epimerase inhibitor | 0.208 0.017 DBMET02982 0.227 0.015 DBMET00376 0.438 0.004 DBMET02983 | DBMET02983 | |
| 0.033 | 0.093 | 0.048 | Parathyroid hormone antagonist | 0.048 0.024 DBMET02982 0.046 0.028 DBMET00376 | DBMET02982 | |
| 0.042 | 0.103 | 0.183 | Porphobilinogen synthase inhibitor | 0.183 0.014 DBMET02982 0.163 0.018 DBMET00376 | DBMET02982 | |
| 0.012 | 0.073 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 DBMET00376 | DBMET00376 | |
| 0.012 | 0.074 | 0.049 | Nicotinic alpha4beta2 receptor agonist | 0.049 0.005 DBMET02982 | DBMET02982 | |
| 0.151 | 0.213 | 0.216 | 5 Hydroxytryptamine 3E antagonist | 0.216 0.04 DBMET02982 0.17 0.136 DBMET00376 | DBMET02982 | |
| 0.051 | 0.116 | 0.096 | Macrophage migration inhibitory factor inhibitor | 0.096 0.037 DBMET02982 0.087 0.044 DBMET00376 | DBMET02982 | |
| 0.068 | 0.133 | 0.112 | GABA C receptor rho-1 antagonist | 0.112 0.047 DBMET02982 0.11 0.05 DBMET00376 | DBMET02982 | |
| 0.009 | 0.075 | 0.037 | CC chemokine 9 receptor antagonist | 0.037 0.003 DBMET02982 | DBMET02982 | |
| 0.05 | 0.116 | 0.234 | Androgen antagonist | 0.226 0.011 DBMET02982 0.234 0.01 DBMET00376 | DBMET00376 | |
| 0.062 | 0.128 | 0.137 | Falcipain 3 inhibitor | 0.137 0.043 DBMET02982 0.104 0.067 DBMET00376 | DBMET02982 | |
| 0.084 | 0.153 | 0.168 | Toll-Like receptor antagonist | 0.168 0.044 DBMET02982 | DBMET02982 | |
| 0.025 | 0.096 | 0.051 | Dihydroorotase inhibitor | 0.051 0.024 DBMET02982 0.047 0.028 DBMET00376 | DBMET02982 | |
| 0.02 | 0.093 | 0.066 | DNA-dependent protein kinase inhibitor | 0.038 0.031 DBMET02982 0.066 0.012 DBMET00376 | DBMET00376 | |
| 0.03 | 0.106 | 0.106 | Glucose-6-phosphate isomerase inhibitor | 0.067 0.014 DBMET02982 0.076 0.01 DBMET00376 0.106 0.004 DBMET02983 | DBMET02983 | |
| 0.033 | 0.109 | 0.242 | Phosphofructokinase-1 inhibitor | 0.103 0.031 DBMET02982 0.13 0.022 DBMET00376 0.242 0.008 DBMET02983 | DBMET02983 | |
| 0.014 | 0.092 | 0.048 | Fumarate hydratase inhibitor | 0.038 0.02 DBMET02982 0.048 0.014 DBMET00376 0.03 0.029 DBMET02983 | DBMET00376 | |
| 0.027 | 0.106 | 0.076 | Argininosuccinate synthase inhibitor | 0.07 0.03 DBMET02982 0.076 0.027 DBMET00376 | DBMET00376 | |
| 0.074 | 0.153 | 0.149 | Nav1.5 sodium channel blocker | 0.149 0.028 DBMET02982 0.102 0.082 DBMET00376 | DBMET02982 | |
| 0.009 | 0.089 | 0.024 | Glutamate (mGluR1a) agonist | 0.024 0.013 DBMET02982 | DBMET02982 | |
| 0.099 | 0.18 | 0.166 | GABA C receptor rho-2 antagonist | 0.166 0.055 DBMET02982 0.136 0.095 DBMET00376 | DBMET02982 | |
| 0.03 | 0.111 | 0.104 | Aconitate hydratase inhibitor | 0.09 0.011 DBMET02982 0.104 0.008 DBMET00376 | DBMET00376 | |
| 0.015 | 0.1 | 0.043 | CC chemokine 3 receptor antagonist | 0.043 0.028 DBMET02982 | DBMET02982 | |
| 0.028 | 0.113 | 0.122 | Protein kinase C theta inhibitor | 0.122 0.005 DBMET02982 0.076 0.017 DBMET00376 | DBMET02982 | |
| 0.109 | 0.194 | 0.168 | CC chemokine 6 receptor antagonist | 0.14 0.04 DBMET02982 0.134 0.057 DBMET00376 0.168 0.009 DBMET02983 | DBMET02983 | |
| 0.008 | 0.094 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.015 DBMET02983 | DBMET02983 | |
| 0.006 | 0.093 | 0.017 | Nicotinic alpha4 receptor agonist | 0.017 0.011 DBMET02982 | DBMET02982 | |
| 0.014 | 0.103 | 0.118 | Estrogen-related receptor alpha antagonist | 0.118 0.005 DBMET02982 0.032 0.023 DBMET00376 | DBMET02982 | |
| 0.017 | 0.105 | 0.034 | Estrogen-related receptor gamma antagonist | 0.033 0.011 DBMET02982 0.034 0.01 DBMET00376 | DBMET00376 | |
| 0.007 | 0.097 | 0.022 | Telomerase stimulant | 0.017 0.013 DBMET00376 0.022 0.006 DBMET02983 | DBMET02983 | |
| 0.005 | 0.095 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.007 DBMET02983 | DBMET02983 | |
| 0.023 | 0.113 | 0.043 | Glutamate (mGluR8) agonist | 0.041 0.02 DBMET02982 0.043 0.018 DBMET00376 | DBMET00376 | |
| 0.019 | 0.109 | 0.081 | Glutamate (mGluR5) antagonist | 0.081 0.014 DBMET02982 | DBMET02982 | |
| 0.056 | 0.147 | 0.118 | Caspase 7 inhibitor | 0.118 0.015 DBMET02982 0.079 0.063 DBMET00376 | DBMET02982 | |
| 0.019 | 0.111 | 0.055 | Ornithine carbamoyltransferase inhibitor | 0.055 0.035 DBMET00376 | DBMET00376 | |
| 0.062 | 0.154 | 0.123 | D-Ala-D-Ala ligase inhibitor | 0.123 0.012 DBMET02982 0.115 0.016 DBMET00376 | DBMET02982 | |
| 0.104 | 0.197 | 0.245 | Insulin sensitizer | 0.245 0.037 DBMET02982 0.167 0.111 DBMET00376 | DBMET02982 | |
| 0.153 | 0.247 | 0.291 | Tyrosine 3 hydroxylase inhibitor | 0.291 0.038 DBMET02982 0.268 0.052 DBMET00376 | DBMET02982 | |
| 0.065 | 0.159 | 0.154 | Glutamate receptor antagonist | 0.154 0.048 DBMET02982 | DBMET02982 | |
| 0.026 | 0.122 | 0.04 | GABA B receptor antagonist | 0.04 0.035 DBMET02982 | DBMET02982 | |
| 0.034 | 0.132 | 0.101 | Histidine decarboxylase inhibitor | 0.088 0.037 DBMET02982 0.101 0.031 DBMET00376 | DBMET00376 | |
| 0.022 | 0.121 | 0.066 | Cathepsin L inhibitor | 0.066 0.033 DBMET02982 0.051 0.049 DBMET00376 | DBMET02982 | |
| 0.029 | 0.129 | 0.17 | Androgen agonist | 0.106 0.013 DBMET02982 0.17 0.006 DBMET00376 | DBMET00376 | |
| 0.03 | 0.13 | 0.071 | Cyclin D1 inhibitor | 0.071 0.027 DBMET02982 | DBMET02982 | |
| 0.035 | 0.136 | 0.067 | Purinergic P2X1 antagonist | 0.065 0.037 DBMET02982 0.067 0.035 DBMET00376 | DBMET00376 | |
| 0.16 | 0.26 | 0.285 | Antiobesity | 0.236 0.17 DBMET00376 0.285 0.127 DBMET02983 | DBMET02983 | |
| 0.036 | 0.14 | 0.074 | Heat shock protein 90 beta antagonist | 0.074 0.025 DBMET02982 | DBMET02982 | |
| 0.02 | 0.124 | 0.116 | Glutamate (mGluR1) antagonist | 0.116 0.012 DBMET02982 | DBMET02982 | |
| 0.101 | 0.206 | 0.648 | Aldehyde oxidase inhibitor | 0.648 0.013 DBMET02982 0.447 0.04 DBMET00376 | DBMET02982 | |
| 0.007 | 0.112 | 0.028 | Adenosine A1 receptor agonist | 0.028 0.013 DBMET02982 | DBMET02982 | |
| 0.024 | 0.13 | 0.106 | Potassium channel (Inward rectifier) blocker | 0.106 0.006 DBMET02982 0.063 0.021 DBMET00376 | DBMET02982 | |
| 0.033 | 0.14 | 0.056 | 5 Hydroxytryptamine 7 agonist | 0.056 0.04 DBMET02982 | DBMET02982 | |
| 0.027 | 0.134 | 0.146 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.146 0.005 DBMET02982 0.082 0.015 DBMET00376 | DBMET02982 | |
| 0.016 | 0.123 | 0.056 | Guanylate cyclase inhibitor | 0.052 0.019 DBMET02982 0.056 0.016 DBMET00376 0.055 0.016 DBMET02983 | DBMET00376 | |
| 0.014 | 0.121 | 0.041 | Glycine transporter inhibitor | 0.041 0.04 DBMET02982 | DBMET02982 | |
| 0.016 | 0.124 | 0.042 | Sphingosine 1-phosphate receptor 1 agonist | 0.042 0.029 DBMET02982 0.041 0.03 DBMET00376 | DBMET02982 | |
| 0.057 | 0.166 | 0.133 | Anabolic | 0.133 0.029 DBMET02982 0.133 0.029 DBMET00376 | DBMET00376 | |
| 0.055 | 0.167 | 0.074 | MAP kinase kinase 7 inhibitor | 0.074 0.064 DBMET02982 0.074 0.065 DBMET00376 | DBMET00376 | |
| 0.115 | 0.228 | 0.16 | Heat shock protein 70 antagonist | 0.16 0.027 DBMET02982 0.155 0.035 DBMET00376 0.155 0.035 DBMET02983 | DBMET02982 | |
| 0.086 | 0.199 | 0.179 | DNA repair enzyme inhibitor | 0.128 0.058 DBMET02982 0.179 0.014 DBMET02983 | DBMET02983 | |
| 0.018 | 0.131 | 0.079 | Thromboxane A2 antagonist | 0.056 0.031 DBMET02982 0.079 0.016 DBMET00376 | DBMET00376 | |
| 0.011 | 0.124 | 0.034 | Phosphoglycerate kinase inhibitor | 0.034 0.025 DBMET00376 | DBMET00376 | |
| 0.008 | 0.121 | 0.039 | CXC chemokine 2 receptor antagonist | 0.039 0.008 DBMET02982 0.025 0.02 DBMET00376 | DBMET02982 | |
| 0.017 | 0.132 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 DBMET00376 | DBMET00376 | |
| 0.019 | 0.135 | 0.033 | Vanilloid 4 antagonist | 0.033 0.02 DBMET02982 | DBMET02982 | |
| 0.033 | 0.151 | 0.109 | Glutamate decarboxylase inhibitor | 0.101 0.029 DBMET02982 0.109 0.025 DBMET00376 | DBMET00376 | |
| 0.034 | 0.154 | 0.097 | Potassium channel intermediate-conductance Ca-activated blocker | 0.097 0.01 DBMET02982 0.057 0.048 DBMET00376 | DBMET02982 | |
| 0.056 | 0.176 | 0.12 | Carbonic anhydrase III inhibitor | 0.12 0.044 DBMET02982 0.114 0.049 DBMET00376 0.089 0.076 DBMET02983 | DBMET02982 | |
| 0.036 | 0.156 | 0.18 | Glutamate (mGluR group I) antagonist | 0.18 0.009 DBMET02982 | DBMET02982 | |
| 0.018 | 0.139 | 0.039 | Glutamate (mGluR3) agonist | 0.039 0.011 DBMET00376 0.031 0.026 DBMET02983 | DBMET00376 | |
| 0.081 | 0.202 | 0.156 | Sphingosine 1-phosphate receptor 2 agonist | 0.156 0.023 DBMET02982 0.133 0.038 DBMET00376 | DBMET02982 | |
| 0.066 | 0.187 | 0.134 | Sodium channel blocker | 0.134 0.071 DBMET02982 | DBMET02982 | |
| 0.053 | 0.175 | 0.161 | Cystathionine beta-synthase inhibitor | 0.161 0.036 DBMET02982 0.159 0.037 DBMET00376 0.115 0.062 DBMET02983 | DBMET02982 | |
| 0.019 | 0.142 | 0.08 | Thromboxane antagonist | 0.053 0.038 DBMET02982 0.08 0.02 DBMET00376 | DBMET00376 | |
| 0.131 | 0.255 | 0.265 | RNA-directed DNA polymerase inhibitor | 0.265 0.042 DBMET02982 0.234 0.061 DBMET00376 0.202 0.097 DBMET02983 | DBMET02982 | |
| 0.154 | 0.278 | 0.305 | 5 Hydroxytryptamine uptake stimulant | 0.305 0.042 DBMET02982 0.276 0.059 DBMET00376 | DBMET02982 | |
| 0.029 | 0.154 | 0.105 | Glutamate receptor agonist | 0.076 0.057 DBMET02982 0.105 0.034 DBMET00376 | DBMET00376 | |
| 0.008 | 0.134 | 0.042 | Dipeptidyl peptidase I inhibitor | 0.042 0.011 DBMET02982 | DBMET02982 | |
| 0.007 | 0.133 | 0.05 | Uridine phosphorylase inhibitor | 0.044 0.01 DBMET02982 0.049 0.008 DBMET00376 0.05 0.008 DBMET02983 | DBMET02983 | |
| 0.018 | 0.145 | 0.072 | Glutamate (mGluR5) agonist | 0.072 0.013 DBMET02982 0.049 0.027 DBMET00376 | DBMET02982 | |
| 0.007 | 0.134 | 0.163 | Progesterone antagonist | 0.086 0.01 DBMET02982 0.163 0.005 DBMET00376 | DBMET00376 | |
| 0.029 | 0.156 | 0.135 | Fatty acid synthase inhibitor | 0.135 0.005 DBMET02982 0.067 0.028 DBMET00376 | DBMET02982 | |
| 0.018 | 0.146 | 0.074 | Glutamate (mGluR1a) antagonist | 0.074 0.01 DBMET02982 | DBMET02982 | |
| 0.083 | 0.213 | 0.175 | Thiol protease inhibitor | 0.175 0.051 DBMET02982 0.121 0.115 DBMET00376 | DBMET02982 | |
| 0.004 | 0.134 | 0.018 | Progesterone agonist | 0.018 0.012 DBMET02982 | DBMET02982 | |
| 0.051 | 0.182 | 0.324 | Triose-phosphate isomerase inhibitor | 0.153 0.019 DBMET02982 0.175 0.014 DBMET00376 0.324 0.004 DBMET02983 | DBMET02983 | |
| 0.011 | 0.142 | 0.033 | Vanilloid 2 agonist | 0.025 0.018 DBMET02982 0.024 0.021 DBMET00376 0.033 0.007 DBMET02983 | DBMET02983 | |
| 0.014 | 0.146 | 0.047 | Dopamine D5 agonist | 0.047 0.02 DBMET02982 0.039 0.029 DBMET00376 | DBMET02982 | |
| 0.008 | 0.14 | 0.099 | Sodium/glucose cotransporter 2 inhibitor | 0.029 0.015 DBMET00376 0.099 0.003 DBMET02983 | DBMET02983 | |
| 0.043 | 0.175 | 0.069 | Transcription factor RelA inhibitor | 0.069 0.032 DBMET02982 0.059 0.057 DBMET00376 | DBMET02982 | |
| 0.094 | 0.229 | 0.189 | Pregnane X receptor agonist | 0.189 0.014 DBMET02982 0.134 0.09 DBMET00376 | DBMET02982 | |
| 0.01 | 0.145 | 0.033 | LFA antagonist | 0.033 0.013 DBMET02982 0.031 0.014 DBMET00376 | DBMET02982 | |
| 0.056 | 0.192 | 0.239 | MAP kinase kinase 1 inhibitor | 0.16 0.013 DBMET02982 0.239 0.004 DBMET00376 | DBMET00376 | |
| 0.008 | 0.143 | 0.017 | 5-Alpha-reductase 2 inhibitor | 0.017 0.016 DBMET02982 0.017 0.016 DBMET00376 | DBMET00376 | |
| 0.036 | 0.174 | 0.089 | Calcium channel L-type blocker | 0.089 0.031 DBMET02982 0.067 0.056 DBMET00376 | DBMET02982 | |
| 0.017 | 0.155 | 0.052 | Dihydroorotate dehydrogenase inhibitor | 0.052 0.035 DBMET00376 | DBMET00376 | |
| 0.029 | 0.167 | 0.055 | MAP kinase kinase 9 inhibitor | 0.055 0.039 DBMET02982 | DBMET02982 | |
| 0.081 | 0.22 | 0.146 | Cyclin-dependent kinase 8 inhibitor | 0.146 0.083 DBMET02982 | DBMET02982 | |
| 0.017 | 0.156 | 0.069 | Integrin alpha2 antagonist | 0.051 0.011 DBMET02982 0.069 0.005 DBMET00376 | DBMET00376 | |
| 0.009 | 0.148 | 0.041 | 5-Alpha-reductase inhibitor | 0.041 0.023 DBMET02982 0.037 0.027 DBMET00376 | DBMET02982 | |
| 0.023 | 0.162 | 0.053 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.053 0.012 DBMET02982 0.05 0.015 DBMET00376 | DBMET02982 | |
| 0.042 | 0.183 | 0.078 | Glutamate (mGluR6) antagonist | 0.073 0.034 DBMET02982 0.078 0.027 DBMET00376 | DBMET00376 | |
| 0.007 | 0.148 | 0.038 | Kynurenine 3 monooxygenase inhibitor | 0.038 0.011 DBMET02982 | DBMET02982 | |
| 0.132 | 0.278 | 0.221 | Nitric-oxide synthase stimulant | 0.221 0.059 DBMET02982 0.21 0.074 DBMET00376 0.192 0.104 DBMET02983 | DBMET02982 | |
| 0.031 | 0.178 | 0.097 | Aminopeptidase I inhibitor | 0.084 0.039 DBMET02982 0.097 0.029 DBMET00376 | DBMET00376 | |
| 0.008 | 0.157 | 0.048 | Cathepsin L1 inhibitor | 0.048 0.021 DBMET02982 | DBMET02982 | |
| 0.036 | 0.186 | 0.234 | Ornithine decarboxylase inhibitor | 0.168 0.007 DBMET02982 0.234 0.004 DBMET00376 0.116 0.029 DBMET02983 | DBMET00376 | |
| 0.063 | 0.214 | 0.113 | CDC-like kinase 3 inhibitor | 0.113 0.053 DBMET02982 | DBMET02982 | |
| 0.051 | 0.202 | 0.136 | Bromodomain-containing protein 2 inhibitor | 0.086 0.062 DBMET02982 0.136 0.014 DBMET00376 | DBMET00376 | |
| 0.097 | 0.248 | 0.221 | Succinate dehydrogenase inhibitor | 0.217 0.037 DBMET02982 0.221 0.035 DBMET00376 | DBMET00376 | |
| 0.008 | 0.16 | 0.048 | Free fatty acid receptor 1 antagonist | 0.048 0.01 DBMET02982 0.045 0.012 DBMET00376 | DBMET02982 | |
| 0.016 | 0.17 | 0.039 | Estrogen-related receptor beta antagonist | 0.036 0.016 DBMET02982 0.039 0.012 DBMET00376 | DBMET00376 | |
| 0.041 | 0.198 | 0.48 | Mediator release inhibitor | 0.088 0.083 DBMET02982 0.132 0.038 DBMET00376 0.48 0.004 DBMET02983 | DBMET02983 | |
| 0.043 | 0.2 | 0.114 | Bronchodilator | 0.095 0.07 DBMET02982 0.114 0.049 DBMET00376 | DBMET00376 | |
| 0.04 | 0.197 | 0.272 | Potassium channel activator | 0.22 0.007 DBMET02982 0.272 0.005 DBMET00376 | DBMET00376 | |
| 0.025 | 0.187 | 0.079 | Protein kinase C beta inhibitor | 0.079 0.032 DBMET02982 | DBMET02982 | |
| 0.007 | 0.169 | 0.092 | Sirtuin 2 inhibitor | 0.092 0.005 DBMET02982 | DBMET02982 | |
| 0.011 | 0.174 | 0.045 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.045 0.012 DBMET02982 | DBMET02982 | |
| 0.047 | 0.211 | 0.196 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.138 0.031 DBMET02982 0.149 0.027 DBMET00376 0.196 0.016 DBMET02983 | DBMET02983 | |
| 0.038 | 0.203 | 0.185 | Inducible nitric-oxide synthase inhibitor | 0.185 0.01 DBMET02982 0.074 0.073 DBMET00376 | DBMET02982 | |
| 0.015 | 0.18 | 0.072 | Adenosine A1 receptor antagonist | 0.072 0.032 DBMET02982 | DBMET02982 | |
| 0.012 | 0.177 | 0.07 | Glutamate (mGluR group I) agonist | 0.07 0.016 DBMET02982 0.048 0.033 DBMET00376 | DBMET02982 | |
| 0.018 | 0.186 | 0.098 | Acetylcholine M5 receptor agonist | 0.098 0.021 DBMET02982 | DBMET02982 | |
| 0.003 | 0.179 | 0.036 | Prostaglandin H2 antagonist | 0.036 0.008 DBMET00376 | DBMET00376 | |
| 0.039 | 0.215 | 0.119 | Keratolytic | 0.117 0.023 DBMET02982 0.119 0.022 DBMET00376 | DBMET00376 | |
| 0.05 | 0.227 | 0.1 | Granulocyte macrophage colony stimulating factor agonist | 0.1 0.034 DBMET02982 0.083 0.066 DBMET00376 | DBMET02982 | |
| 0.041 | 0.219 | 0.107 | Glycogen synthase kinase-3 alpha inhibitor | 0.107 0.097 DBMET02982 | DBMET02982 | |
| 0.029 | 0.208 | 0.117 | Calcium antagonist | 0.117 0.037 DBMET02982 | DBMET02982 | |
| 0.032 | 0.211 | 0.074 | Glutamate (mGluR7) antagonist | 0.074 0.035 DBMET02982 0.068 0.047 DBMET00376 | DBMET02982 | |
| 0.175 | 0.355 | 0.343 | 5 Hydroxytryptamine release inhibitor | 0.343 0.121 DBMET02982 0.328 0.135 DBMET00376 0.326 0.137 DBMET02983 | DBMET02982 | |
| 0.008 | 0.189 | 0.077 | Sodium/glucose cotransporter inhibitor | 0.024 0.023 DBMET00376 0.077 0.004 DBMET02983 | DBMET02983 | |
| 0.127 | 0.309 | 0.354 | Insulysin inhibitor | 0.354 0.033 DBMET02982 0.215 0.135 DBMET00376 | DBMET02982 | |
| 0.021 | 0.208 | 0.045 | Kainate receptor agonist | 0.042 0.026 DBMET02982 0.045 0.021 DBMET00376 | DBMET00376 | |
| 0.008 | 0.197 | 0.087 | Estradiol 17 beta-dehydrogenase inhibitor | 0.086 0.012 DBMET02982 0.087 0.012 DBMET00376 | DBMET00376 | |
| 0.049 | 0.238 | 0.174 | Beta amyloid protein antagonist | 0.145 0.044 DBMET02982 0.174 0.026 DBMET00376 0.164 0.031 DBMET02983 | DBMET00376 | |
| 0.037 | 0.227 | 0.178 | Glycine receptor agonist | 0.178 0.005 DBMET02982 0.098 0.022 DBMET00376 0.098 0.022 DBMET02983 | DBMET02982 | |
| 0.096 | 0.287 | 0.391 | Cyclic AMP phosphodiesterase inhibitor | 0.286 0.048 DBMET02982 0.349 0.026 DBMET00376 0.391 0.018 DBMET02983 | DBMET02983 | |
| 0.162 | 0.355 | 0.311 | MAP kinase 1 inhibitor | 0.311 0.168 DBMET02982 | DBMET02982 | |
| 0.034 | 0.227 | 0.116 | Aminopeptidase B inhibitor | 0.103 0.063 DBMET02982 0.116 0.055 DBMET00376 | DBMET00376 | |
| 0.012 | 0.205 | 0.047 | GABA uptake inhibitor | 0.047 0.018 DBMET00376 | DBMET00376 | |
| 0.01 | 0.205 | 0.052 | ATP citrate lysase inhibitor | 0.03 0.024 DBMET02982 0.052 0.007 DBMET00376 | DBMET00376 | |
| 0.015 | 0.212 | 0.041 | MAP3K5 inhibitor | 0.041 0.024 DBMET02982 | DBMET02982 | |
| 0.015 | 0.214 | 0.078 | Prolyl endopeptidase inhibitor | 0.078 0.011 DBMET02982 | DBMET02982 | |
| 0.053 | 0.252 | 0.148 | Cytokine production inhibitor | 0.148 0.064 DBMET00376 | DBMET00376 | |
| 0.03 | 0.229 | 0.085 | GABA aminotransferase inhibitor | 0.085 0.041 DBMET02983 | DBMET02983 | |
| 0.055 | 0.255 | 0.149 | NADPH oxidase inhibitor | 0.149 0.055 DBMET02982 | DBMET02982 | |
| 0.021 | 0.222 | 0.101 | Phenylalanine 4-hydroxylase inhibitor | 0.08 0.037 DBMET02982 0.101 0.025 DBMET00376 | DBMET00376 | |
| 0.003 | 0.206 | 0.048 | Prostaglandin E2 agonist | 0.048 0.006 DBMET00376 | DBMET00376 | |
| 0.02 | 0.225 | 0.063 | Leukotriene B4 antagonist | 0.059 0.029 DBMET00376 0.063 0.024 DBMET02983 | DBMET02983 | |
| 0.043 | 0.249 | 0.228 | Beta glucuronidase inhibitor | 0.095 0.077 DBMET02982 0.228 0.01 DBMET02983 | DBMET02983 | |
| 0.046 | 0.253 | 0.105 | Electrolyte absorption antagonist | 0.105 0.051 DBMET02982 0.094 0.066 DBMET00376 | DBMET02982 | |
| 0.036 | 0.243 | 0.119 | Histamine H2 receptor antagonist | 0.119 0.021 DBMET02982 0.088 0.051 DBMET00376 | DBMET02982 | |
| 0.031 | 0.238 | 0.144 | Alcohol dehydrogenase inhibitor | 0.144 0.022 DBMET02982 | DBMET02982 | |
| 0.007 | 0.214 | 0.03 | Antibiotic Anthracycline-like | 0.03 0.004 DBMET02983 | DBMET02983 | |
| 0.008 | 0.215 | 0.026 | Retinoid X beta receptor antagonist | 0.026 0.006 DBMET02982 | DBMET02982 | |
| 0.02 | 0.229 | 0.103 | Sphingosine 1-phosphate receptor 4 agonist | 0.103 0.023 DBMET02982 0.095 0.028 DBMET00376 | DBMET02982 | |
| 0.053 | 0.264 | 0.229 | Aldehyde dehydrogenase inhibitor | 0.208 0.026 DBMET02982 0.229 0.022 DBMET00376 0.155 0.044 DBMET02983 | DBMET00376 | |
| 0.013 | 0.224 | 0.039 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 DBMET02982 0.039 0.019 DBMET00376 0.039 0.019 DBMET02983 | DBMET02983 | |
| 0.017 | 0.228 | 0.079 | Dopamine uptake inhibitor | 0.079 0.026 DBMET00376 | DBMET00376 | |
| 0.005 | 0.218 | 0.058 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.058 0.006 DBMET02982 | DBMET02982 | |
| 0.016 | 0.23 | 0.063 | TRPA1 antagonist | 0.063 0.039 DBMET02982 | DBMET02982 | |
| 0.096 | 0.31 | 0.344 | Superoxide dismutase inhibitor | 0.344 0.038 DBMET02982 0.232 0.087 DBMET00376 | DBMET02982 | |
| 0.068 | 0.284 | 0.204 | I kappa B kinase epsilon inhibitor | 0.204 0.068 DBMET02982 | DBMET02982 | |
| 0.002 | 0.219 | 0.014 | Imidazoline I2 receptor antagonist | 0.014 0.005 DBMET02982 | DBMET02982 | |
| 0.01 | 0.228 | 0.034 | Integrin alpha2beta1 antagonist | 0.026 0.019 DBMET02982 0.034 0.009 DBMET00376 | DBMET00376 | |
| 0.014 | 0.241 | 0.051 | Retinoid X alpha receptor antagonist | 0.051 0.005 DBMET02982 0.044 0.011 DBMET00376 | DBMET02982 | |
| 0.123 | 0.35 | 0.551 | Histamine release inhibitor | 0.36 0.095 DBMET00376 0.551 0.016 DBMET02983 | DBMET02983 | |
| 0.016 | 0.244 | 0.097 | Alpha-mannosidase inhibitor | 0.057 0.031 DBMET00376 0.097 0.007 DBMET02983 | DBMET02983 | |
| 0.031 | 0.259 | 0.055 | Leukotriene C antagonist | 0.055 0.042 DBMET02982 | DBMET02982 | |
| 0.024 | 0.253 | 0.146 | Cathepsin G inhibitor | 0.142 0.022 DBMET02982 0.146 0.022 DBMET00376 | DBMET00376 | |
| 0.021 | 0.25 | 0.049 | Squalene epoxidase inhibitor | 0.049 0.035 DBMET02982 | DBMET02982 | |
| 0.047 | 0.279 | 0.14 | Microtubule formation inhibitor | 0.135 0.047 DBMET02982 0.14 0.043 DBMET02983 | DBMET02983 | |
| 0.042 | 0.274 | 0.324 | Amylase inhibitor | 0.229 0.034 DBMET02982 0.108 0.089 DBMET00376 0.324 0.015 DBMET02983 | DBMET02983 | |
| 0.005 | 0.238 | 0.065 | Prostaglandin agonist | 0.065 0.008 DBMET00376 | DBMET00376 | |
| 0.058 | 0.293 | 0.215 | Arachidonic acid antagonist | 0.215 0.02 DBMET02982 0.209 0.025 DBMET00376 0.155 0.082 DBMET02983 | DBMET02982 | |
| 0.015 | 0.252 | 0.059 | Retinoid X receptor antagonist | 0.059 0.007 DBMET02982 0.05 0.013 DBMET00376 | DBMET02982 | |
| 0.083 | 0.32 | 0.252 | ATPase inhibitor | 0.212 0.028 DBMET02982 0.208 0.031 DBMET00376 0.252 0.013 DBMET02983 | DBMET02983 | |
| 0.07 | 0.308 | 0.208 | Melanin inhibitor | 0.159 0.07 DBMET02982 0.154 0.077 DBMET00376 0.208 0.038 DBMET02983 | DBMET02983 | |
| 0.011 | 0.251 | 0.097 | Mannosidase inhibitor | 0.045 0.032 DBMET00376 0.097 0.006 DBMET02983 | DBMET02983 | |
| 0.007 | 0.246 | 0.024 | Lysophosphatidic acid 1 receptor antagonist | 0.024 0.011 DBMET00376 | DBMET00376 | |
| 0.008 | 0.251 | 0.042 | Thyroid hormone agonist | 0.026 0.017 DBMET02982 0.042 0.005 DBMET00376 | DBMET00376 | |
| 0.001 | 0.245 | 0.011 | Thyroid hormone beta agonist | 0.011 0.005 DBMET00376 | DBMET00376 | |
| 0.011 | 0.255 | 0.052 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.052 0.01 DBMET02982 0.048 0.013 DBMET00376 | DBMET02982 | |
| 0.026 | 0.272 | 0.124 | Potassium channel (Ca-activated) activator | 0.112 0.046 DBMET02982 0.124 0.038 DBMET00376 | DBMET00376 | |
| 0.033 | 0.28 | 0.11 | Prolactin inhibitor | 0.11 0.046 DBMET02982 0.099 0.057 DBMET00376 | DBMET02982 | |
| 0.037 | 0.285 | 0.337 | MAP kinase kinase inhibitor | 0.186 0.033 DBMET02982 0.337 0.005 DBMET00376 | DBMET00376 | |
| 0.035 | 0.285 | 0.12 | Interleukin 1 beta converting enzyme inhibitor | 0.12 0.035 DBMET02982 0.089 0.073 DBMET00376 | DBMET02982 | |
| 0.121 | 0.372 | 0.475 | Calcium channel activator | 0.475 0.007 DBMET02982 0.303 0.088 DBMET00376 | DBMET02982 | |
| 0.026 | 0.278 | 0.081 | Secretase beta inhibitor | 0.081 0.035 DBMET02982 0.081 0.034 DBMET00376 | DBMET00376 | |
| 0.035 | 0.287 | 0.095 | 5 Hydroxytryptamine 3A agonist | 0.095 0.082 DBMET02982 | DBMET02982 | |
| 0.052 | 0.305 | 0.216 | Interleukin 8 antagonist | 0.216 0.009 DBMET02982 0.108 0.08 DBMET00376 | DBMET02982 | |
| 0.018 | 0.271 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.084 0.047 DBMET02982 0.11 0.023 DBMET00376 0.116 0.019 DBMET02983 | DBMET02983 | |
| 0.046 | 0.304 | 0.115 | Antibacterial (Helicobacter pylori) | 0.115 0.09 DBMET02982 0.113 0.093 DBMET00376 | DBMET02982 | |
| 0.026 | 0.284 | 0.092 | Histamine N-methyltransferase inhibitor | 0.092 0.053 DBMET02982 0.082 0.064 DBMET00376 | DBMET02982 | |
| 0.049 | 0.308 | 0.174 | Acetylcholine M1 receptor antagonist | 0.174 0.056 DBMET00376 | DBMET00376 | |
| 0.008 | 0.272 | 0.03 | Acid ceramidase inhibitor | 0.03 0.009 DBMET02982 | DBMET02982 | |
| 0.003 | 0.27 | 0.037 | Prostaglandin EP2 agonist | 0.037 0.009 DBMET00376 | DBMET00376 | |
| 0.009 | 0.277 | 0.057 | Cathepsin L2 inhibitor | 0.057 0.019 DBMET02982 | DBMET02982 | |
| 0.066 | 0.335 | 0.145 | Adenylate cyclase stimulant | 0.142 0.077 DBMET02982 0.145 0.071 DBMET00376 | DBMET00376 | |
| 0.005 | 0.276 | 0.029 | HCV NS5B polymerase inhibitor | 0.029 0.025 DBMET00376 | DBMET00376 | |
| 0.01 | 0.282 | 0.084 | Cannabinoid receptor agonist | 0.084 0.033 DBMET02982 | DBMET02982 | |
| 0.046 | 0.318 | 0.137 | LIM domain kinase 1 inhibitor | 0.137 0.112 DBMET02982 | DBMET02982 | |
| 0.018 | 0.291 | 0.117 | MAO A inhibitor | 0.117 0.054 DBMET02982 | DBMET02982 | |
| 0.085 | 0.361 | 0.261 | Transcription factor STAT3 inhibitor | 0.261 0.075 DBMET02982 0.231 0.1 DBMET00376 | DBMET02982 | |
| 0.03 | 0.308 | 0.162 | Nitric-oxide synthase inhibitor | 0.162 0.018 DBMET02982 | DBMET02982 | |
| 0.023 | 0.302 | 0.061 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.05 DBMET02982 | DBMET02982 | |
| 0.005 | 0.286 | 0.031 | Glutamate (mGluR2) agonist | 0.031 0.024 DBMET00376 | DBMET00376 | |
| 0.02 | 0.302 | 0.146 | Potassium channel (ATP-sensitive) blocker | 0.146 0.005 DBMET02982 0.082 0.026 DBMET00376 | DBMET02982 | |
| 0.022 | 0.307 | 0.053 | Pregnane X receptor antagonist | 0.053 0.051 DBMET02982 | DBMET02982 | |
| 0.034 | 0.324 | 0.125 | Estrogen receptor alpha antagonist | 0.125 0.017 DBMET02982 0.115 0.02 DBMET00376 | DBMET02982 | |
| 0.008 | 0.299 | 0.042 | Glutamate (mGluR group II) agonist | 0.042 0.019 DBMET00376 | DBMET00376 | |
| 0.02 | 0.312 | 0.047 | CXC chemokine 1 receptor antagonist | 0.047 0.043 DBMET02982 | DBMET02982 | |
| 0.011 | 0.305 | 0.1 | Carbonic anhydrase XIV inhibitor | 0.045 0.039 DBMET02982 0.078 0.017 DBMET00376 0.1 0.011 DBMET02983 | DBMET02983 | |
| 0.021 | 0.315 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.047 DBMET02982 | DBMET02982 | |
| 0.006 | 0.303 | 0.046 | Liver X receptor beta antagonist | 0.046 0.01 DBMET02982 | DBMET02982 | |
| 0.017 | 0.313 | 0.05 | Sphingosine kinase 2 inhibitor | 0.05 0.047 DBMET02982 | DBMET02982 | |
| 0.003 | 0.302 | 0.04 | Arginase inhibitor | 0.04 0.023 DBMET02983 | DBMET02983 | |
| 0.016 | 0.315 | 0.063 | Cytokine production stimulant | 0.063 0.01 DBMET02983 | DBMET02983 | |
| 0.023 | 0.324 | 0.081 | Glucosylceramidase inhibitor | 0.081 0.015 DBMET00376 0.054 0.04 DBMET02983 | DBMET00376 | |
| 0.014 | 0.316 | 0.132 | Bromodomain-containing protein 4 inhibitor | 0.132 0.008 DBMET00376 | DBMET00376 | |
| 0.032 | 0.334 | 0.113 | Alkaline phosphatase inhibitor | 0.113 0.096 DBMET02982 0.111 0.098 DBMET02983 | DBMET02982 | |
| 0.009 | 0.312 | 0.125 | MAO B inhibitor | 0.125 0.048 DBMET02982 | DBMET02982 | |
| 0.02 | 0.324 | 0.048 | Topoisomerase II beta inhibitor | 0.048 0.037 DBMET00376 | DBMET00376 | |
| 0.078 | 0.384 | 0.234 | Histone acetyltransferase inhibitor | 0.234 0.034 DBMET02982 0.215 0.049 DBMET00376 | DBMET02982 | |
| 0.046 | 0.352 | 0.234 | MAP kinase kinase 2 inhibitor | 0.234 0.062 DBMET02982 | DBMET02982 | |
| 0.038 | 0.344 | 0.166 | Pyruvate kinase inhibitor | 0.166 0.103 DBMET02982 | DBMET02982 | |
| 0.051 | 0.358 | 0.221 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.221 0.089 DBMET02982 | DBMET02982 | |
| 0.019 | 0.327 | 0.078 | Phospholipase D inhibitor | 0.078 0.037 DBMET02982 | DBMET02982 | |
| 0.049 | 0.357 | 0.13 | Glutamate release inhibitor | 0.13 0.016 DBMET02982 0.086 0.071 DBMET00376 0.104 0.037 DBMET02983 | DBMET02982 | |
| 0.053 | 0.362 | 0.115 | Transcription factor STAT6 inhibitor | 0.115 0.069 DBMET02982 | DBMET02982 | |
| 0.052 | 0.364 | 0.236 | Hexokinase inhibitor | 0.236 0.02 DBMET02982 0.155 0.073 DBMET00376 0.231 0.022 DBMET02983 | DBMET02982 | |
| 0.028 | 0.34 | 0.112 | Protein kinase C gamma inhibitor | 0.112 0.06 DBMET02982 | DBMET02982 | |
| 0.01 | 0.322 | 0.055 | NMDA receptor glycine site agonist | 0.055 0.051 DBMET02982 | DBMET02982 | |
| 0.044 | 0.359 | 0.141 | TRPA1 agonist | 0.141 0.037 DBMET02982 0.11 0.072 DBMET00376 | DBMET02982 | |
| 0.041 | 0.358 | 0.09 | Carbonic anhydrase XV inhibitor | 0.09 0.084 DBMET02982 | DBMET02982 | |
| 0.081 | 0.401 | 0.156 | Neurotensin receptor agonist | 0.156 0.088 DBMET02982 | DBMET02982 | |
| 0.008 | 0.329 | 0.035 | RNA-directed RNA polymerase inhibitor | 0.035 0.023 DBMET00376 | DBMET00376 | |
| 0.013 | 0.334 | 0.148 | Catalase inhibitor | 0.148 0.026 DBMET02982 0.071 0.054 DBMET00376 | DBMET02982 | |
| 0.079 | 0.401 | 0.699 | Cholesterol antagonist | 0.45 0.041 DBMET02982 0.627 0.015 DBMET00376 0.699 0.008 DBMET02983 | DBMET02983 | |
| 0.127 | 0.449 | 0.492 | MAP kinase kinase 3 inhibitor | 0.492 0.002 DBMET00376 | DBMET00376 | |
| 0.039 | 0.361 | 0.216 | Diuretic | 0.187 0.05 DBMET02982 0.216 0.039 DBMET00376 0.215 0.039 DBMET02983 | DBMET00376 | |
| 0.073 | 0.396 | 0.372 | DNA synthesis inhibitor | 0.194 0.132 DBMET02982 0.251 0.065 DBMET00376 0.372 0.026 DBMET02983 | DBMET02983 | |
| 0.017 | 0.345 | 0.146 | Platelet growth factor antagonist | 0.146 0.02 DBMET02982 | DBMET02982 | |
| 0.028 | 0.357 | 0.108 | Acetylcholine muscarinic antagonist | 0.108 0.08 DBMET00376 | DBMET00376 | |
| 0.007 | 0.335 | 0.029 | Peptide deformylase inhibitor | 0.029 0.023 DBMET02982 | DBMET02982 | |
| 0.011 | 0.339 | 0.066 | Leukotriene antagonist | 0.066 0.044 DBMET00376 | DBMET00376 | |
| 0.042 | 0.374 | 0.12 | Nav1.2 sodium channel blocker | 0.12 0.084 DBMET00376 | DBMET00376 | |
| 0.004 | 0.337 | 0.05 | Carbonic anhydrase I inhibitor | 0.05 0.043 DBMET02982 | DBMET02982 | |
| 0.015 | 0.349 | 0.064 | Dopamine D1 antagonist | 0.064 0.046 DBMET00376 | DBMET00376 | |
| 0.013 | 0.348 | 0.042 | Phenylethanolamine N methyltransferase inhibitor | 0.042 0.025 DBMET02982 | DBMET02982 | |
| 0.031 | 0.367 | 0.149 | Cytidine deaminase inhibitor | 0.149 0.076 DBMET02982 | DBMET02982 | |
| 0.082 | 0.419 | 0.255 | 5 Hydroxytryptamine release stimulant | 0.255 0.087 DBMET02982 0.243 0.092 DBMET00376 | DBMET02982 | |
| 0.004 | 0.344 | 0.053 | Carbonic anhydrase II inhibitor | 0.053 0.041 DBMET02982 | DBMET02982 | |
| 0.002 | 0.347 | 0.015 | Human herpes virus 5 capsid protein P40 inhibitor | 0.015 0.006 DBMET02982 | DBMET02982 | |
| 0.04 | 0.387 | 0.173 | Potassium channel (Voltage-sensitive) blocker | 0.172 0.119 DBMET02982 0.173 0.117 DBMET00376 | DBMET00376 | |
| 0.016 | 0.364 | 0.14 | MAO inhibitor | 0.14 0.065 DBMET02982 | DBMET02982 | |
| 0.055 | 0.404 | 0.247 | 3C-like protease (Human coronavirus) inhibitor | 0.247 0.029 DBMET02982 | DBMET02982 | |
| 0.061 | 0.413 | 0.313 | 12-Lipoxygenase inhibitor | 0.313 0.072 DBMET02982 0.227 0.124 DBMET00376 | DBMET02982 | |
| 0.038 | 0.391 | 0.159 | Photosensitizer | 0.159 0.026 DBMET02982 0.1 0.088 DBMET00376 0.136 0.041 DBMET02983 | DBMET02982 | |
| 0.025 | 0.382 | 0.118 | Sphingomyelinase inhibitor | 0.108 0.051 DBMET00376 0.118 0.042 DBMET02983 | DBMET02983 | |
| 0.017 | 0.374 | 0.108 | Heparanase inhibitor | 0.052 0.038 DBMET02982 0.108 0.004 DBMET02983 | DBMET02983 | |
| 0.021 | 0.378 | 0.077 | Interferon inducer | 0.06 0.053 DBMET00376 0.077 0.026 DBMET02983 | DBMET02983 | |
| 0.016 | 0.378 | 0.061 | MAP kinase kinase 10 inhibitor | 0.061 0.057 DBMET02982 | DBMET02982 | |
| 0.027 | 0.398 | 0.164 | HIV-1 integrase (Overall Integration) inhibitor | 0.164 0.021 DBMET02982 0.086 0.069 DBMET00376 | DBMET02982 | |
| 0.047 | 0.419 | 0.388 | Vasodilator | 0.222 0.088 DBMET02982 0.159 0.144 DBMET00376 0.388 0.025 DBMET02983 | DBMET02983 | |
| 0.046 | 0.418 | 0.21 | P-glycoprotein inhibitor | 0.21 0.058 DBMET02982 0.151 0.115 DBMET02983 | DBMET02982 | |
| 0.012 | 0.387 | 0.286 | HIV-1 reverse transcriptase inhibitor | 0.286 0.005 DBMET02982 0.24 0.007 DBMET00376 | DBMET02982 | |
| 0.033 | 0.412 | 0.122 | Phospholipase A2 inhibitor | 0.122 0.113 DBMET02982 | DBMET02982 | |
| 0.033 | 0.413 | 0.149 | HERG channel blocker | 0.149 0.132 DBMET00376 | DBMET00376 | |
| 0.004 | 0.385 | 0.04 | Leukotriene B4 receptor 1 antagonist | 0.04 0.012 DBMET00376 | DBMET00376 | |
| 0.032 | 0.418 | 0.135 | Toll-Like receptor 2 antagonist | 0.135 0.063 DBMET02982 | DBMET02982 | |
| 0.046 | 0.433 | 0.143 | Antipruritic | 0.143 0.103 DBMET00376 | DBMET00376 | |
| 0.004 | 0.394 | 0.055 | Carbonic anhydrase inhibitor | 0.055 0.05 DBMET02982 | DBMET02982 | |
| 0.014 | 0.406 | 0.193 | Expectorant | 0.193 0.022 DBMET02983 | DBMET02983 | |
| 0.05 | 0.443 | 0.273 | Lipoxygenase inhibitor | 0.236 0.11 DBMET02982 0.273 0.085 DBMET00376 | DBMET00376 | |
| 0.018 | 0.412 | 0.092 | Interferon agonist | 0.092 0.036 DBMET02983 | DBMET02983 | |
| 0.004 | 0.402 | 0.042 | Liver X receptor beta agonist | 0.042 0.014 DBMET02982 0.031 0.027 DBMET00376 | DBMET02982 | |
| 0.006 | 0.403 | 0.067 | Leukocyte elastase inhibitor | 0.067 0.015 DBMET02982 0.038 0.037 DBMET00376 | DBMET02982 | |
| 0.005 | 0.406 | 0.064 | Elastase 2 inhibitor | 0.064 0.004 DBMET02982 | DBMET02982 | |
| 0.005 | 0.406 | 0.064 | Elastase 2A inhibitor | 0.064 0.004 DBMET02982 | DBMET02982 | |
| 0.019 | 0.421 | 0.101 | Mucolytic | 0.101 0.076 DBMET02982 | DBMET02982 | |
| 0.03 | 0.433 | 0.124 | Protein kinase stimulant | 0.124 0.088 DBMET02983 | DBMET02983 | |
| 0.02 | 0.426 | 0.052 | CD45 antagonist | 0.052 0.031 DBMET02982 | DBMET02982 | |
| 0.021 | 0.427 | 0.17 | CDC-like kinase 1 inhibitor | 0.17 0.055 DBMET02982 | DBMET02982 | |
| 0.008 | 0.414 | 0.055 | Liver X receptor alpha agonist | 0.055 0.015 DBMET02982 0.044 0.025 DBMET00376 | DBMET02982 | |
| 0.005 | 0.412 | 0.084 | Catechol O-methyltransferase inhibitor | 0.084 0.005 DBMET02982 0.036 0.019 DBMET00376 | DBMET02982 | |
| 0.035 | 0.443 | 0.188 | Cyclooxygenase 3 inhibitor | 0.188 0.023 DBMET02983 | DBMET02983 | |
| 0.07 | 0.48 | 0.635 | Antibacterial | 0.285 0.147 DBMET00376 0.635 0.015 DBMET02983 | DBMET02983 | |
| 0.057 | 0.473 | 0.243 | Transcription factor STAT inhibitor | 0.243 0.091 DBMET02982 0.206 0.13 DBMET00376 | DBMET02982 | |
| 0.045 | 0.462 | 0.242 | DNA polymerase beta inhibitor | 0.242 0.197 DBMET02982 | DBMET02982 | |
| 0.105 | 0.527 | 0.435 | Caspase 9 stimulant | 0.4 0.111 DBMET02982 0.326 0.167 DBMET00376 0.435 0.091 DBMET02983 | DBMET02983 | |
| 0.039 | 0.465 | 0.347 | Hemostatic | 0.125 0.104 DBMET02982 0.347 0.012 DBMET02983 | DBMET02983 | |
| 0.033 | 0.462 | 0.096 | Phosphodiesterase 6D inhibitor | 0.093 0.067 DBMET02982 0.096 0.061 DBMET02983 | DBMET02983 | |
| 0.041 | 0.469 | 0.306 | Interleukin agonist | 0.25 0.079 DBMET02982 0.306 0.045 DBMET02983 | DBMET02983 | |
| 0.01 | 0.439 | 0.129 | Elastase inhibitor | 0.129 0.005 DBMET02982 0.092 0.012 DBMET00376 | DBMET02982 | |
| 0.01 | 0.442 | 0.079 | Neuraminidase (influenza) inhibitor | 0.079 0.026 DBMET02983 | DBMET02983 | |
| 0.015 | 0.45 | 0.095 | Glycine receptor antagonist | 0.095 0.037 DBMET02983 | DBMET02983 | |
| 0.012 | 0.447 | 0.148 | MAP kinase 11 inhibitor | 0.148 0.018 DBMET02982 | DBMET02982 | |
| 0.031 | 0.467 | 0.302 | Prostaglandin dehydrogenase inhibitor | 0.302 0.101 DBMET02982 | DBMET02982 | |
| 0.015 | 0.456 | 0.123 | Urease inhibitor | 0.123 0.042 DBMET00376 | DBMET00376 | |
| 0.021 | 0.466 | 0.082 | Carbonic anhydrase VI inhibitor | 0.082 0.055 DBMET02982 | DBMET02982 | |
| 0.01 | 0.457 | 0.105 | Anesthetic local | 0.105 0.078 DBMET00376 | DBMET00376 | |
| 0.044 | 0.493 | 0.234 | Calpain 2 inhibitor | 0.234 0.161 DBMET02982 | DBMET02982 | |
| 0.035 | 0.492 | 0.278 | Non-steroidal antiinflammatory agent | 0.278 0.033 DBMET02982 0.236 0.049 DBMET02983 | DBMET02982 | |
| 0.018 | 0.475 | 0.061 | Beta 3 adrenoreceptor antagonist | 0.061 0.053 DBMET00376 | DBMET00376 | |
| 0.042 | 0.5 | 0.562 | Cardiotonic | 0.562 0.01 DBMET02982 0.517 0.014 DBMET00376 0.177 0.143 DBMET02983 | DBMET02982 | |
| 0.014 | 0.475 | 0.066 | Beta 2 adrenoreceptor agonist | 0.066 0.028 DBMET00376 | DBMET00376 | |
| 0.012 | 0.473 | 0.107 | Adrenaline agonist | 0.107 0.032 DBMET00376 | DBMET00376 | |
| 0.02 | 0.482 | 0.074 | Glutathione S-transferase inhibitor | 0.074 0.073 DBMET02982 | DBMET02982 | |
| 0.011 | 0.477 | 0.047 | Beta adrenoreceptor agonist | 0.047 0.024 DBMET00376 | DBMET00376 | |
| 0.039 | 0.509 | 0.226 | DNA directed DNA polymerase inhibitor | 0.226 0.207 DBMET02982 | DBMET02982 | |
| 0.024 | 0.494 | 0.1 | Bile acid receptor antagonist | 0.1 0.049 DBMET02982 | DBMET02982 | |
| 0.033 | 0.505 | 0.294 | Alpha-glucosidase inhibitor | 0.224 0.203 DBMET02982 0.294 0.163 DBMET02983 | DBMET02983 | |
| 0.018 | 0.492 | 0.171 | Aryl hydrocarbon receptor agonist | 0.171 0.12 DBMET02982 | DBMET02982 | |
| 0.025 | 0.506 | 0.391 | Spasmolytic | 0.252 0.09 DBMET00376 0.391 0.042 DBMET02983 | DBMET02983 | |
| 0.014 | 0.496 | 0.084 | Glucose-6-phosphate translocase inhibitor | 0.084 0.01 DBMET02983 | DBMET02983 | |
| 0.014 | 0.496 | 0.134 | Clk dual-specificity kinase inhibitor | 0.134 0.13 DBMET02982 | DBMET02982 | |
| 0.011 | 0.499 | 0.126 | Stem cell growth factor agonist | 0.126 0.028 DBMET02982 | DBMET02982 | |
| 0.052 | 0.543 | 0.269 | Gastrin inhibitor | 0.269 0.058 DBMET02982 0.191 0.162 DBMET00376 | DBMET02982 | |
| 0.007 | 0.499 | 0.194 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.194 0.014 DBMET00376 | DBMET00376 | |
| 0.011 | 0.504 | 0.08 | Beta adrenoreceptor antagonist | 0.08 0.027 DBMET00376 | DBMET00376 | |
| 0.016 | 0.51 | 0.145 | Factor IXa inhibitor | 0.145 0.004 DBMET00376 0.128 0.005 DBMET02983 | DBMET00376 | |
| 0.009 | 0.504 | 0.056 | Beta 2 adrenoreceptor antagonist | 0.056 0.028 DBMET00376 | DBMET00376 | |
| 0.043 | 0.542 | 0.139 | Vanilloid 1 agonist | 0.122 0.083 DBMET00376 0.139 0.052 DBMET02983 | DBMET02983 | |
| 0.022 | 0.525 | 0.174 | Potassium channel blocker | 0.174 0.111 DBMET02982 | DBMET02982 | |
| 0.011 | 0.517 | 0.077 | Peroxisome proliferator-activated receptor gamma antagonist | 0.077 0.038 DBMET02982 | DBMET02982 | |
| 0.008 | 0.513 | 0.095 | CC chemokine receptor antagonist | 0.095 0.038 DBMET02982 | DBMET02982 | |
| 0.006 | 0.513 | 0.13 | Monophenol monooxygenase inhibitor | 0.13 0.056 DBMET02983 | DBMET02983 | |
| 0.042 | 0.553 | 0.17 | Neurotrophic factor enhancer | 0.17 0.11 DBMET02982 0.146 0.144 DBMET00376 | DBMET02982 | |
| 0.011 | 0.525 | 0.055 | Acetyl-CoA transferase 2 inhibitor | 0.055 0.043 DBMET02982 | DBMET02982 | |
| 0.02 | 0.536 | 0.424 | Immunostimulant | 0.424 0.043 DBMET02983 | DBMET02983 | |
| 0.026 | 0.542 | 0.14 | DNA methyltransferase I inhibitor | 0.14 0.116 DBMET02982 | DBMET02982 | |
| 0.005 | 0.522 | 0.591 | 5 Hydroxytryptamine uptake inhibitor | 0.591 0.004 DBMET00376 0.098 0.027 DBMET02983 | DBMET00376 | |
| 0.037 | 0.556 | 0.539 | Transcription factor NF kappa B inhibitor | 0.223 0.148 DBMET02982 0.319 0.086 DBMET00376 0.539 0.039 DBMET02983 | DBMET02983 | |
| 0.031 | 0.551 | 0.442 | Nitric oxide antagonist | 0.144 0.1 DBMET00376 0.442 0.021 DBMET02983 | DBMET02983 | |
| 0.038 | 0.56 | 0.206 | Tumour necrosis factor antagonist | 0.206 0.05 DBMET02982 | DBMET02982 | |
| 0.013 | 0.536 | 0.157 | Anesthetic general | 0.157 0.106 DBMET02983 | DBMET02983 | |
| 0.006 | 0.531 | 0.072 | Neuraminidase inhibitor | 0.072 0.032 DBMET02983 | DBMET02983 | |
| 0.004 | 0.536 | 0.048 | Cannabinoid CB2 receptor agonist | 0.048 0.045 DBMET02982 | DBMET02982 | |
| 0.039 | 0.573 | 0.591 | Antithrombotic | 0.242 0.132 DBMET02982 0.331 0.071 DBMET00376 0.591 0.017 DBMET02983 | DBMET02983 | |
| 0.013 | 0.557 | 0.177 | Elastase 1 inhibitor | 0.177 0.005 DBMET02982 | DBMET02982 | |
| 0.013 | 0.56 | 0.189 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.189 0.048 DBMET02982 | DBMET02982 | |
| 0.004 | 0.564 | 0.064 | Prostaglandin-E synthase inhibitor | 0.064 0.057 DBMET02982 | DBMET02982 | |
| 0.003 | 0.571 | 0.048 | Phosphorylase inhibitor | 0.048 0.031 DBMET02983 | DBMET02983 | |
| 0.024 | 0.591 | 0.159 | DNA methylase inhibitor | 0.135 0.132 DBMET02982 0.159 0.11 DBMET02983 | DBMET02983 | |
| 0.003 | 0.571 | 0.022 | Calcium-sensing receptor antagonist | 0.022 0.008 DBMET00376 | DBMET00376 | |
| 0.005 | 0.584 | 0.024 | Potassium channel (Inward rectifier) 11 blocker | 0.024 0.005 DBMET02982 | DBMET02982 | |
| 0.007 | 0.607 | 0.136 | Alkylator | 0.136 0.054 DBMET02983 | DBMET02983 | |
| 0.007 | 0.607 | 0.114 | Chemokine receptor antagonist | 0.114 0.052 DBMET02982 | DBMET02982 | |
| 0.046 | 0.649 | 0.289 | MAP kinase kinase 4 inhibitor | 0.278 0.004 DBMET02982 0.289 0.004 DBMET00376 | DBMET00376 | |
| 0.02 | 0.63 | 0.28 | Antiamyloidogenic | 0.28 0.059 DBMET02983 | DBMET02983 | |
| 0.004 | 0.668 | 0.055 | Glucocorticoid antagonist | 0.055 0.013 DBMET00376 | DBMET00376 | |
| 0.019 | 0.684 | 0.092 | MAP kinase 7 inhibitor | 0.092 0.016 DBMET02982 | DBMET02982 | |
| 0.026 | 0.707 | 0.229 | Toll-Like receptor 7 agonist | 0.229 0.168 DBMET00376 | DBMET00376 | |
| 0.005 | 0.707 | 0.523 | Check point kinase 2 inhibitor | 0.129 0.042 DBMET02982 0.523 0.004 DBMET00376 | DBMET00376 | |
| 0.022 | 0.727 | 0.218 | Toll-Like receptor agonist | 0.218 0.181 DBMET00376 | DBMET00376 | |
| 0.008 | 0.715 | 0.077 | Cyclin B3 inhibitor | 0.077 0.04 DBMET02982 | DBMET02982 | |
| 0.007 | 0.724 | 0.11 | p38 MAP kinase inhibitor | 0.11 0.029 DBMET02982 | DBMET02982 | |
| 0.003 | 0.721 | 0.265 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.144 0.004 DBMET02982 0.265 0.003 DBMET00376 | DBMET00376 | |
| 0.005 | 0.725 | 0.208 | Protein kinase C delta inhibitor | 0.208 0.008 DBMET02982 | DBMET02982 | |
| 0.029 | 0.776 | 0.119 | Sigma receptor agonist | 0.119 0.116 DBMET02982 | DBMET02982 | |
| 0.005 | 0.752 | 0.067 | Cyclin B1 inhibitor | 0.067 0.035 DBMET02982 | DBMET02982 | |
| 0.004 | 0.754 | 0.062 | Cyclin B2 inhibitor | 0.062 0.029 DBMET02982 | DBMET02982 | |
| 0.004 | 0.77 | 0.049 | Cyclin B inhibitor | 0.049 0.047 DBMET02982 | DBMET02982 | |
| 0.005 | 0.778 | 0.286 | Adrenaline uptake inhibitor | 0.286 0.004 DBMET00376 0.074 0.031 DBMET02983 | DBMET00376 | |
| 0.004 | 0.779 | 0.327 | Dopamine transporter inhibitor | 0.327 0.003 DBMET00376 0.162 0.005 DBMET02983 | DBMET00376 | |
| 0.02 | 0.802 | 0.088 | T cell inhibitor | 0.088 0.041 DBMET00376 0.079 0.071 DBMET02983 | DBMET00376 | |
| 0.009 | 0.792 | 0.105 | MAP kinase 12 inhibitor | 0.105 0.09 DBMET02982 | DBMET02982 | |
| 0.002 | 0.816 | 0.033 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.033 0.002 DBMET02982 | DBMET02982 | |
| 0.015 | 0.833 | 0.125 | MAP3K9 inhibitor | 0.125 0.104 DBMET00376 | DBMET00376 | |
| 0.005 | 0.827 | 0.089 | Maillard reaction inhibitor | 0.089 0.021 DBMET00376 | DBMET00376 | |
| 0.012 | 0.836 | 0.089 | Ca(v)3.2 blocker | 0.089 0.011 DBMET00376 | DBMET00376 | |
| 0.005 | 0.836 | 0.259 | Cyclooxygenase 1 inhibitor | 0.259 0.019 DBMET02982 | DBMET02982 | |
| 0.023 | 0.862 | 0.252 | Growth factor agonist | 0.252 0.031 DBMET02982 | DBMET02982 | |
| 0 | 0.847 | 0.01 | Insulin like growth factor 3 antagonist | 0.007 0.004 DBMET02982 0.01 0.003 DBMET00376 | DBMET00376 | |
| 0.014 | 0.871 | 0.75 | Antiinflammatory | 0.384 0.149 DBMET02982 0.451 0.11 DBMET00376 0.75 0.022 DBMET02983 | DBMET02983 | |
| 0.019 | 0.879 | 0.165 | Transcription factor NF kappa B stimulant | 0.165 0.013 DBMET02983 | DBMET02983 | |
| 0.003 | 0.864 | 0.09 | Raf kinase C inhibitor | 0.09 0.028 DBMET02982 | DBMET02982 | |
| 0.01 | 0.871 | 0.746 | Cyclophilin D inhibitor | 0.246 0.218 DBMET02982 0.332 0.136 DBMET00376 0.746 0.01 DBMET02983 | DBMET02983 | |
| 0.005 | 0.869 | 0.214 | Cyclooxygenase inhibitor | 0.214 0.036 DBMET02982 | DBMET02982 | |
| 0.004 | 0.869 | 0.083 | Leukotriene synthesis inhibitor | 0.083 0.035 DBMET00376 | DBMET00376 | |
| 0.004 | 0.883 | 0.149 | Estrogen receptor beta antagonist | 0.149 0.016 DBMET02982 | DBMET02982 | |
| 0.008 | 0.887 | 0.306 | Interleukin 1 antagonist | 0.306 0.01 DBMET02982 | DBMET02982 | |
| 0.005 | 0.885 | 0.317 | Tumour necrosis factor alpha release inhibitor | 0.161 0.144 DBMET02982 0.317 0.047 DBMET02983 | DBMET02983 | |
| 0.004 | 0.894 | 0.285 | Lipid peroxidase inhibitor | 0.285 0.021 DBMET02983 | DBMET02983 | |
| 0.005 | 0.896 | 0.14 | Dual specificity phosphatase 3 inhibitor | 0.14 0.106 DBMET02982 | DBMET02982 | |
| 0.013 | 0.904 | 0.161 | DNA polymerase I inhibitor | 0.161 0.043 DBMET02983 | DBMET02983 | |
| 0.006 | 0.901 | 0.063 | Elastase 3A inhibitor | 0.063 0.003 DBMET02982 | DBMET02982 | |
| 0.006 | 0.901 | 0.063 | Elastase 3B inhibitor | 0.063 0.003 DBMET02982 | DBMET02982 | |
| 0.006 | 0.901 | 0.063 | Elastase 2B inhibitor | 0.063 0.003 DBMET02982 | DBMET02982 | |
| 0.006 | 0.904 | 0.155 | Dual specificity phosphatase inhibitor | 0.155 0.089 DBMET02982 | DBMET02982 | |
| 0.013 | 0.912 | 0.208 | Interleukin 4 antagonist | 0.143 0.056 DBMET02982 0.158 0.043 DBMET00376 0.208 0.02 DBMET02983 | DBMET02983 | |
| 0.004 | 0.903 | 0.373 | Tubulin antagonist | 0.373 0.013 DBMET02982 | DBMET02982 | |
| 0.005 | 0.908 | 0.262 | Platelet antagonist | 0.179 0.118 DBMET00376 0.262 0.067 DBMET02983 | DBMET02983 | |
| 0.01 | 0.913 | 0.505 | Immunosuppressant | 0.505 0.032 DBMET02983 | DBMET02983 | |
| 0.004 | 0.91 | 0.107 | Protein-tyrosine phosphatase 1B inhibitor | 0.107 0.072 DBMET02983 | DBMET02983 | |
| 0.004 | 0.912 | 0.13 | 5-Lipoxygenase inhibitor | 0.13 0.046 DBMET00376 | DBMET00376 | |
| 0.003 | 0.926 | 0.069 | Protein kinase C epsilon inhibitor | 0.069 0.024 DBMET02982 | DBMET02982 | |
| 0.005 | 0.941 | 0.108 | Transcription factor AP-1 inhibitor | 0.072 0.028 DBMET02982 0.108 0.011 DBMET00376 | DBMET00376 | |
| 0.003 | 0.941 | 0.366 | Selectin antagonist | 0.366 0.004 DBMET02983 | DBMET02983 | |
| 0.019 | 0.957 | 0.264 | NOS3 expression enhancer | 0.264 0.024 DBMET02983 | DBMET02983 | |
| 0.003 | 0.945 | 0.034 | Protein kinase C beta I inhibitor | 0.034 0.021 DBMET02982 | DBMET02982 | |
| 0.004 | 0.947 | 0.077 | Antibiotic Aminoglycoside-like | 0.077 0.005 DBMET02983 | DBMET02983 | |
| 0.004 | 0.948 | 0.115 | Cyclooxygenase 2 inhibitor | 0.115 0.085 DBMET02982 | DBMET02982 | |
| 0.003 | 0.949 | 0.106 | Protein kinase C eta inhibitor | 0.106 0.015 DBMET02982 | DBMET02982 | |
| 0 | 0.947 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 DBMET02983 | DBMET02983 | |
| 0.003 | 0.951 | 0.159 | Alpha tubulin antagonist | 0.159 0.009 DBMET02982 0.109 0.014 DBMET00376 | DBMET02982 | |
| 0.002 | 0.954 | 0.045 | Microtubule stabilization | 0.045 0.034 DBMET02983 | DBMET02983 | |
| 0.004 | 0.955 | 0.103 | CDC25A inhibitor | 0.103 0.026 DBMET02982 | DBMET02982 | |
| 0.001 | 0.953 | 0.021 | Corticosteroid-like | 0.021 0.016 DBMET02983 | DBMET02983 | |
| 0.013 | 0.965 | 0.201 | Caspase 3 stimulant | 0.201 0.168 DBMET02983 | DBMET02983 | |
| 0.004 | 0.956 | 0.174 | Topoisomerase I inhibitor | 0.174 0.033 DBMET02983 | DBMET02983 | |
| 0.031 | 0.991 | 0.384 | Peptidyltransferase inhibitor | 0.384 0.008 DBMET02983 | DBMET02983 | |
| 0.004 | 0.968 | 0.552 | Antioxidant | 0.552 0.015 DBMET02983 | DBMET02983 | |
| 0.027 | 0.992 | 0.604 | Calcium channel L-type activator | 0.604 0.005 DBMET02982 | DBMET02982 | |
| 0.005 | 0.97 | 0.414 | Immunomodulator | 0.414 0.04 DBMET02983 | DBMET02983 | |
| 0.005 | 0.972 | 0.58 | Hypoglycemic | 0.58 0.009 DBMET02983 | DBMET02983 | |
| 0.002 | 0.97 | 0.145 | Beta tubulin antagonist | 0.145 0.013 DBMET02982 | DBMET02982 | |
| 0.004 | 0.973 | 0.29 | Antimitotic | 0.29 0.046 DBMET02982 | DBMET02982 | |
| 0.001 | 0.972 | 0.023 | Leukotriene B4 receptor 2 antagonist | 0.023 0.014 DBMET02983 | DBMET02983 | |
| 0.003 | 0.975 | 0.075 | CDC25B inhibitor | 0.075 0.033 DBMET02982 | DBMET02982 | |
| 0.004 | 0.979 | 0.323 | Hypolipemic | 0.323 0.042 DBMET00376 0.312 0.045 DBMET02983 | DBMET00376 | |
| 0.003 | 0.98 | 0.106 | Protein 50S ribosomal subunit inhibitor | 0.106 0.012 DBMET02983 | DBMET02983 | |
| 0.018 | 0.995 | 0.495 | Interleukin 2 agonist | 0.296 0.076 DBMET02982 0.495 0.009 DBMET02983 | DBMET02983 | |
| 0.005 | 0.981 | 0.184 | Insulin secretagoues | 0.184 0.045 DBMET02983 | DBMET02983 | |
| 0.004 | 0.984 | 0.485 | Free radical scavenger | 0.485 0.018 DBMET02983 | DBMET02983 | |
| 0.004 | 0.984 | 0.206 | Interleukin antagonist | 0.206 0.08 DBMET02982 | DBMET02982 | |
| 0.005 | 0.985 | 0.339 | Interleukin 1b antagonist | 0.339 0.007 DBMET02982 | DBMET02982 | |
| 0.009 | 0.991 | 0.067 | Lipocortins synthesis agonist | 0.067 0.024 DBMET02983 | DBMET02983 | |
| 0.003 | 0.986 | 0.147 | Cell adhesion molecule inhibitor | 0.147 0.016 DBMET02983 | DBMET02983 | |
| 0.002 | 0.985 | 0.196 | Antineoplastic antibiotic | 0.196 0.022 DBMET02983 | DBMET02983 | |
| 0.004 | 0.988 | 0.276 | Cell adhesion inhibitor | 0.097 0.096 DBMET00376 0.276 0.012 DBMET02983 | DBMET02983 | |
| 0.003 | 0.988 | 0.096 | Topoisomerase II alpha inhibitor | 0.096 0.042 DBMET02983 | DBMET02983 | |
| 0.005 | 0.989 | 0.421 | Apoptosis antagonist | 0.421 0.033 DBMET02983 | DBMET02983 | |
| 0.005 | 0.991 | 0.465 | Hepatoprotectant | 0.465 0.009 DBMET02983 | DBMET02983 | |
| 0.004 | 0.99 | 0.073 | Autotaxin inhibitor | 0.073 0.021 DBMET02982 | DBMET02982 | |
| 0.004 | 0.991 | 0.469 | Apoptosis agonist | 0.469 0.084 DBMET02983 | DBMET02983 | |
| 0.005 | 0.995 | 0.166 | Toll-Like receptor 4 antagonist | 0.166 0.014 DBMET02983 | DBMET02983 | |
| 0.005 | 0.996 | 0.535 | Adenine nucleotide translocase inhibitor | 0.535 0.001 DBMET02983 | DBMET02983 | |
| 0.004 | 0.995 | 0.396 | Platelet adhesion inhibitor | 0.138 0.121 DBMET00376 0.396 0.012 DBMET02983 | DBMET02983 | |
| 0.002 | 0.994 | 0.047 | Neuraminidase (Influenza A) inhibitor | 0.047 0.028 DBMET02983 | DBMET02983 | |
| 0.004 | 0.995 | 0.134 | Farnesoid X receptor antagonist | 0.134 0.075 DBMET02982 | DBMET02982 | |
| 0.003 | 0.995 | 0.25 | Anticoagulant | 0.25 0.039 DBMET02983 | DBMET02983 | |
| 0.003 | 0.995 | 0.406 | Thrombolytic | 0.134 0.095 DBMET00376 0.406 0.011 DBMET02983 | DBMET02983 | |
| 0.003 | 0.996 | 0.703 | Angiogenesis stimulant | 0.703 0.005 DBMET02983 | DBMET02983 | |
| 0.002 | 0.996 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 DBMET02983 | DBMET02983 | |
| 0.002 | 0.996 | 0.148 | Topoisomerase II inhibitor | 0.148 0.051 DBMET02983 | DBMET02983 | |
| 0.002 | 0.996 | 0.086 | ATPase (Vacuolar H+) inhibitor | 0.086 0.063 DBMET02983 | DBMET02983 | |
| 0.001 | 0.995 | 0.136 | Squalene synthetase inhibitor | 0.136 0.004 DBMET00376 0.043 0.017 DBMET02983 | DBMET00376 | |
| 0.001 | 0.996 | 0.05 | Protein 30S ribosomal subunit inhibitor | 0.05 0.008 DBMET02983 | DBMET02983 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |